On June 7, 2011, Intellicell Biosciences, Inc. (the "Company") entered into a
security agreement (the "Security Agreement") with TCA Global Credit Master
Fund, LP, a Cayman Islands limited partnership ("TCA"), related to a $500,000
convertible promissory note issued by the Company in favor of TCA (the
"Convertible Note"). The Security Agreement grants to TCA a continuing, first
priority security interest in all of the Company's assets, wheresoever located
and whether now existing or hereafter arising or acquired.

The above description of the Security Agreement and Convertible Note does not
purport to be complete and is qualified in its entirety by the full text of the
document itself. See Item 2.03 herein, which is incorporated by reference in
this Item 1.01.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.

Convertible Promissory Note

On June 7, 2012, the Company issued the Convertible Note in favor of TCA. The
maturity date of the Convertible Note is June 7, 2013, and the Convertible Note
bears interest at a rate of twelve percent (12%) per annum. The Convertible Note
is convertible into shares of the Company's common stock, par value $0.001 per
share (the "Common Stock") at a price equal to ninety-five percent (95%) of the
average of the lowest daily volume weighted average price of the Common Stock
during the five (5) trading days immediately prior to the date of
conversion. The Convertible Note may be prepaid in whole or in part at the
Company's option without penalty.

Item 3.02 Unregistered Sales of Equity Securities

In addition, the Company is relying on an exemption from the registration
requirements of the Securities Act of 1933, as amended, for the private
placement of our securities underlying the Convertible Note pursuant to Section
4(2) of the Act and/or Rule 506 of Regulation D promulgated thereunder. The
transaction does not involve a public offering, TCA is an "accredited investor"
and/or qualified institutional buyer and TCA has access to information about us
and its investment.

Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description
10.1 Convertible Note, dated June 7, 2012, issued by the
Company in favor of TCA